Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.34 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28249451 | 0.89 | ALOX15 (0.44) | ALOX15PTPN1ALDH1A1CHRM5CHRM1 | |
| SCHEMBL3504497 | 0.88 | ALOX15 (0.40) | ALOX15PTPN1TSHRBLMEPHX1 | |
| SCHEMBL28301762 | 0.86 | CHRNB2 (0.46) | ALOX15PTPN1CHRM5CHRM1CHRM3 | |
| SCHEMBL21067009 | 0.85 | ALOX15 (0.56) | ALOX15PTPN1ALDH1A1CHRM5CHRM1 | |
| SCHEMBL21067033 | 0.85 | NAAA (0.41) | ALOX15PTPN1TSHRGAA | |
| SCHEMBL21067035 | 0.85 | NAAA (0.41) | ALOX15PTPN1TSHRGAA | |
| SCHEMBL3506899 | 0.85 | NAAA (0.41) | ALOX15PTPN1TSHRGAA | |
| SCHEMBL3505384 | 0.83 | PTPN1 (0.39) | ALOX15PTPN1ALDH1A1TSHRBLM | |
| SCHEMBL3504718 | 0.83 | DGKA (0.40) | ALOX15PTPN1ALDH1A1TSHRCYP3A4 | |
| SCHEMBL6854700 | 0.83 | TSHR (0.46) | ALOX15PTPN1ALDH1A1TSHRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025078032-A1 | USE OF POROUS STARCH AS FISH BAIT CARRIER | ROQUETTE FRERES (FR) | 2025-04-17 | — | — | WO | claimed |
| EP-4537674-A1 | USE OF POROUS STARCH AS FISH BAIT CARRIER | ROQUETTE FRERES (FR) | 2025-04-16 | — | — | EP | claimed |
| WO-2025068206-A1 | PERFUME COMPOSITIONS | GIVAUDAN SA (CH) | 2025-04-03 | — | — | WO | claimed |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2024-05-30 | — | — | US | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| EP-4319715-A1 | FRAGRANCE COMPOSITION | Givaudan SA (CH) | 2024-02-14 | — | — | EP | claimed |
| WO-2022214636-A1 | FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2022-10-13 | — | — | WO | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | disclosed |
| WO-2026089957-A1 | HOME CARE COMPOSITIONS AND METHODS | COLGATE-PALMOLIVE COMPANY (US) | 2026-04-30 | — | — | WO | disclosed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| US-20260076366-A1 | SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS | 0903608 B C LTD (CA) | 2026-03-19 | — | — | US | disclosed |
| EP-4709160-A1 | STABLE OIL-IN-WATER MICROEMULSION COMPOSITIONS | S.C. Johnson & Son, Inc. (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-2920139-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2015-09-23 | — | — | EP | disclosed |
| US-8969484-B2 | Methods of producing mono- and multi-functional polymers from terpene-based initiators | CHEVRON ORONITE COMPANY LLC (US) | 2015-03-03 | — | — | US | disclosed |
| WO-2014198709-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2014-12-18 | — | — | WO | disclosed |
| US-20140221269-A1 | OLFACTORY SIGNATURE AND ODORANT MIXTURE HAVING THE SAME | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2014-08-07 | — | — | US | disclosed |
| US-20130012662-A1 | METHODS OF PRODUCING MONO- AND MULTI-FUNCTIONAL POLYMERS FROM TERPENE-BASED INITIATORS | CHEVRON ORONITE COMPANY LLC | 2013-01-10 | — | — | US | disclosed |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | THE PROCTER & GAMBLE COMPANY | 2012-04-05 | — | — | US | disclosed |
| US-20100248390-A1 | COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS | DUKE UNIVERSITY (US) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | ALOX15 4169/4885PTPN1 3562/4885ALDH1A1 4813/4885 |
| US-20260076366-A1 | SYNERGISTIC PESTICIDAL COMPOSITIONS AND METHODS FOR DELIVERY OF ACTIVE INGREDIENTS | TACR3, GSTO1, TIAL1 | ALOX15 38/4885PTPN1 4242/4885ALDH1A1 3336/4885 |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | ALOX15 1236/4885PTPN1 3395/4885ALDH1A1 4390/4885 |
| US-20240173230-A1 | FRAGRANCE COMPOSITION | FABP2, FABP5, FAAH2 | ALOX15 14/4885PTPN1 3066/4885ALDH1A1 413/4885 |
| US-20120082628-A1 | Oral Care Compositions With Improved Flavor | TRPA1, TAS2R40, TAS2R30 | ALOX15 1135/4885PTPN1 1778/4885ALDH1A1 1558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.